ELI LILLY & Co is 583.1x more valuable than ANI PHARMACEUTICALS INC by market capitalization ($1.072 T vs $1.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ANIP | LLY |
|---|---|---|
| Market cap | $1.84 B | $1.072 T |
| US-listed rank | #2158 | #10 |
| Revenue (latest FY) | $883.37M | $65.18B |
| Net income (latest FY) | $78.00M | $20.64B |
| Net margin | 8.8% | 31.7% |
| P/E (trailing FY) | 23.6 | 51.9 |
| SEC filings | 1,742 | 989 |
ELI LILLY & Co is 583.1x more valuable than ANI PHARMACEUTICALS INC by market capitalization ($1.072 T vs $1.84 B).
In their latest fiscal years, ANI PHARMACEUTICALS INC reported $883.37M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: ANI PHARMACEUTICALS INC and ELI LILLY & Co, or browse the full rankings.